The problem
Without a transfer pricing curve, lending can look profitable because it uses cheap deposits that may not stay. Branches compete for deposits the institution does not need, and products are priced on yesterday's cost of funds. With a documented curve, ALCO can see which products earn their funding cost and their share of the liquidity buffer.
What it does
- Funding plan: projected balance sheet growth, funding sources by type, tenor and concentration, and actual funding tracked against plan.
- Transfer pricing curve: a base curve plus a term liquidity premium and the cost of holding the liquidity buffer, matched to the maturity and behaviour of each product.
- Product and branch profitability after funds transfer pricing, for assets and liabilities alike.
- Versioned methods: curves, methods and premia are versioned and approved like every other assumption in Noēsis, so a profitability report can always be reproduced.
- ALCO reporting on funding against plan, the cost of new funding and product margins after transfer pricing.
What stays with your institution
Your ALCO approves the transfer pricing method, the curve and the premia, and sets product pricing. Noēsis Funding calculates, records and reports on the basis you approve.
Who it is for
- Treasurers and CFOs at mid-sized banks and finance companies who need a funding plan and a defensible internal price for funds.
- Business heads who need product profitability measured on a consistent basis.
See Noēsis Funding on your own data
Three-month pilots on your data, with no fee for the pilot.